Oxymorphone: a review


Oxymorphone (oxymorphone hydrochloride) (14-hydroxy-dihydromorphinone), a semisynthetic μ-opioid agonist, was first approved by the US Food and Drug Administration in 1959. Oxymorphone is considered a more potent opioid than its parent compound, morphine. Recently, an immediate-release and long-acting oral formulation of this drug was developed that makes oxymorphone a new option in treating moderate to severe pain. This article reviews the pharmacodynamics, pharmacology, and clinical efficacy for this new option in treating moderate to severe pain.

DOI: 10.1007/s00520-005-0917-1

2 Figures and Tables

Citations per Year

373 Citations

Semantic Scholar estimates that this publication has 373 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Prommer2005OxymorphoneAR, title={Oxymorphone: a review}, author={Eric E. Prommer}, journal={Supportive Care in Cancer}, year={2005}, volume={14}, pages={109-115} }